BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Genetown

  Coronado Biosciences Files Registration Statement for Proposed Public Offering

  June 4, 2012

   · 

  1 min read
• FDA

  FDA Clears Erchonia Medical’s Zerona Laser for the Non-Invasive Reduction of the Arms

  June 4, 2012

   · 

  2 min read
• Drug Development

  Active Biotech AB, Ipsen Present Encouraging OS Data from Tasquinimod Phase II Study in CRPC

  June 4, 2012

   · 

  9 min read
• Pharm Country

  West Pharmaceutical Services Announces Purchase Price for Cash Tender Offer for Any and All of Its 4.00% Convertible Junior Subordinated Debentures Due 2047

  June 4, 2012

   · 

  4 min read
• Drug Development

  Medivation, Inc. and Astellas Pharma Inc. Announce Enzalutamide Data Relating to Quality of Life Measures and Extension of Time to First Skeletal-Related Event

  June 4, 2012

   · 

  5 min read
• Business

  Astellas Pharma Inc. and Drais Pharmaceuticals Partner to Develop Second Astellas Compound Through Seldar

  June 4, 2012

   · 

  5 min read
• Genetown

  Industry Visionaries Provide Fresh Perspectives at IBC Life Sciences’s 2012 BioProcess International Conference & Exhibition

  June 4, 2012

   · 

  2 min read
• Drug Development

  Exelixis, Inc. Release: Cabozantinib Demonstrates Evidence of Anti-tumor Effects in Heavily Pretreated Patients With Hepatocellular Carcinoma

  June 4, 2012

   · 

  4 min read
• Drug Development

  NewLink Genetics HyperAcute(R) Lung (tergenpumatucel-L) Immunotherapy Demonstrates a Correlation Between Immune Response and Survival in Patients With Non-Small Cell Lung Cancer

  June 4, 2012

   · 

  1 min read
• Drug Development

  Momenta Pharmaceuticals, Inc. Announces Presentation of Data Supporting Clinical Development of Novel Oncology Drug Candidate M402

  June 4, 2012

   · 

  1 min read